Feedback / Questions
nanoencapsulated paclitaxel (FID-007) - ANP Technologies, Fulgent Genetics
https://www.businesswire.com/news/home/20230518005678/en/Fulgent-Announces-Upcoming-Presentation-of-Clinical-Data-for-Its-Lead-Therapeutic-Oncology-Candidate-FID-007-at-ASCO-2023-Annual-Meeting
May 18, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next